drugset / Trial / NCT01871974
Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder
Non-randomizedSingle-groupOpen-labelOther
Summary
The objective of the study was to evaluate the safety and plasma concentration changes of quetiapine after multiple oral administration of FK949E (extended-release formulation of quetiapine) in patients with major depressive disorder (MDD).
Timeline
- Start
- 2009-05
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quetiapine | Small molecule | — | Oral |